Cryoport (CYRX) EBITDA (2010 - 2026)

Cryoport (CYRX) has reported EBITDA for 17 consecutive years, with -$10.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 4.04% year-over-year to -$10.0 million in Q2 2026; TTM through Jun 2026 was -$39.6 million, a 7.82% increase from a year earlier, with the FY2025 full-year figure at -$36.8 million, up 69.75% from the prior year.
• EBITDA was -$10.0 million for Q2 2026 at Cryoport, down from -$9.6 million in the prior quarter.
• Over five years, EBITDA peaked at -$5.2 million in Q2 2022 and troughed at -$78.0 million in Q2 2024.
• A 5-year average of -$17.3 million and a median of -$10.0 million in 2023 frame the typical range for EBITDA.
• Across the five-year window, EBITDA plunged 584.68% in 2022 and soared 87.63% in 2025, its largest moves.
• Over 5 years, EBITDA stood at -$11.0 million in 2022, then sank by 400.69% to -$55.3 million in 2023, then jumped by 76.93% to -$12.7 million in 2024, then grew by 21.29% to -$10.0 million in 2025, then declined by 0.08% to -$10.0 million in 2026.
• The last three EBITDA figures came in at -$10.0 million (Q2 2026), -$9.6 million (Q1 2026), and -$10.0 million (Q4 2025), per Business Quant data.